Valvosoft First-In-Human Study in Severe Symptomatic Aortic Stenosis

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 23, 2019

Primary Completion Date

June 15, 2022

Study Completion Date

May 23, 2024

Conditions
Aortic Valve Stenosis
Interventions
DEVICE

Ultrasound treatment

Ultrasound treatment of calcified aortic valve causing symptomatic aortic valve stenosis in patients who are not eligible for valve replacemen

Trial Locations (1)

11000

Clinical Centre of Serbia, Belgrade

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cardiawave SA

INDUSTRY

NCT04665596 - Valvosoft First-In-Human Study in Severe Symptomatic Aortic Stenosis | Biotech Hunter | Biotech Hunter